C

Christopher Gagliardi

Principal
💼 Partner bei Sanofi Ventures →
Über

Chris joined Sanofi Ventures in 2017 with a background in life science and healthcare consulting. He previously spent three years as a management consultant at L.E.K. consulting where his work focused on corporate strategy, due diligence, commercial launch planning and asset valuation across the pharmaceutical, biotech, R&D and API manufacturing sectors. Chris currently serves on the Boards of AdvanCell Isotopes, i2O Therapeutics, Minervax, and Sudo Bio, and is a Board observer for Atalanta Therapeutics, Avilar Therapeutics, Matchpoint Therapeutics, and Nextpoint Therapeutics. He also led Sanofi Ventures’ investment in Curevo. Prior to a postdoctoral fellowship at Harvard University, Chris earned a Ph.D. in Chemistry from the University of North Carolina at Chapel Hill as well as a B.S. in both Biology and Chemistry from Roger Williams University.

Schwerpunkte

BioTech, Therapeutics

Region

📍 Ansässig in Cambridge

Verifizierte Kontakte & Outreach Agenten

Direktes E-Mail-Muster

[email protected] | [email protected]

KI Outreach Agenten Pitch Writer

Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...

Direkten Partnerkontakt freischalten

Erhalte Zugriff auf verifizierte Kontakte und nutze unseren Outreach Composer, um Anschreiben in Sekundenschnelle zu entwerfen.

Über GRID kontaktieren

100% kostenloses Konto · Start in 1 Klick